Showing results (11-20 of 35) with videos related to

Sort By:
Pageof 4
Molecular Systems Biology|August 30, 2019
Reply to "CRISPR screens are feasible in TP53 wild-type cells"Emma Haapaniemi, Sandeep Botla, Jenna Persson, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 30, 2008
Mathematical modeling identifies Smad nucleocytoplasmic shuttling as a dynamic signal-interpreting systemBernhard Schmierer, Alexander L Tournier, Paul A Bates, et al.
Science Signaling|September 25, 2014
Response to comment on "Controlling long-term signaling: receptor dynamics determine attenuation and refractory behavior of the TGF-β pathway"-Smad2/3 activity does not predict the dynamics of transcriptionPedro Vizán, Daniel S J Miller, Bernhard Schmierer, et al.
Integrative Biology : Quantitative Biosciences From Nano to Macro|January 18, 2011
Studying Smad2 intranuclear diffusion dynamics by mathematical modelling of FRAP experimentsVinicio González-Pérez, Bernhard Schmierer, Caroline S Hill, et al.
Journal of Cell Science|July 29, 2004
Analysis of Smad nucleocytoplasmic shuttling in living cellsFrancisco J Nicolás, Karolien De Bosscher, Bernhard Schmierer, et al.
The CRISPR Journal|May 7, 2025
Green Listed v2.0: A Web Application for Streamlined Design of Custom CRISPR ScreensEsbjörn Henkel, Zhaojun Li, Daniel Uvehag, et al.
Molecular Systems Biology|October 11, 2017
CRISPR/Cas9 screening using unique molecular identifiersBernhard Schmierer, Sandeep K Botla, Jilin Zhang, et al.
Development (Cambridge, England)|August 14, 2008
Two highly related regulatory subunits of PP2A exert opposite effects on TGF-beta/Activin/Nodal signallingJulie Batut, Bernhard Schmierer, Jing Cao, et al.
Science Signaling|December 12, 2013
Controlling long-term signaling: receptor dynamics determine attenuation and refractory behavior of the TGF-β pathwayPedro Vizán, Daniel S J Miller, Ilaria Gori, et al.
EJNMMI Radiopharmacy and Chemistry|April 18, 2024
Radiolabeled 15-mer peptide internalization is mediated by megalin (LRP2 receptor) in a CRISPR/Cas9-based LRP2 knockout human kidney cell modelAnna Durinova, Lucie Smutna, Pavel Barta, et al.
Pageof 4